![Geoffrey Chaiken](https://aspenideasfestival.imgix.net/27444424-7e24-496a-949c-322e7d33c0b0/Geoffrey-Chaiken.jpg?auto=compress%2Cformat&fit=min&fm=jpg&h=290&q=80&rect=0%2C0%2C1000%2C1000&w=290)
Geoffrey Chaiken
Co-Founder and CEO, Blink Health
Geoffrey Chaiken is co-founder and CEO of Blink Health, launched in February 2016, which allows patients regardless of insurance status to pay for lower-price prescriptions online before picking them up at their preferred pharmacy. He was previously one of three investors at Brave Warrior Advisors, managing $3 billion and leading the firm’s successful investment throughout the technology and pharmaceutical supply chains. Earlier in his career, Chaiken founded Marinus Pharmaceuticals, a specialty pharmaceutical company developing treatments for severe epilepsy where he developed the company’s original strategy, licensed its lead product, and concluded the company’s $30 million series of financing, the largest financing of its kind in Connecticut history.
Previously
![Deep Dive: Drug Prices and Access to Medicine](https://aspenideasfestival.imgix.net/nullc0d7e07a-4eeb-41b8-97d8-1cac72dcbb1c/27621077330_7420a7234f_h.jpg?auto=compress%2Cformat&fit=min&fm=jpg&h=225&q=80&rect=0%2C7%2C1600%2C900&w=400)
The average annual cost of cancer drugs in the US now exceeds $100,000 and the price of more than 200 generic drugs doubled from 2013 to 2014. That puts them far out of reach...